Morgan Stanley lowered the firm’s price target on Bowhead Specialty (BOW) to $29 from $31 and keeps an Equal Weight rating on the shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty’s Q3 2025 Earnings: Strong Growth Amid Challenges
- Bowhead Specialty Holdings Reports Strong Q3 2025 Results
- Bowhead Specialty Reports Strong Q3 Financial Results
- Bowhead Specialty reports Q3 adjusted EPS 47c, consensus 41c
- Bowhead Specialty price target lowered to $40 from $43 at Citizens JMP